Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹15Cr
Rev Gr TTM
Revenue Growth TTM
-34.22%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

APIL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -29.6 | 38.8 | 16.8 | 51.1 | 32.1 | -4.5 | -28.8 | -20.4 | 52.3 | -45.3 | -78.7 | -70.8 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Operating Profit Operating ProfitCr |
| 16.1 | 0.9 | 16.0 | 4.2 | 1.9 | 4.7 | 5.6 | -7.1 | 0.6 | -65.5 | -284.2 | -142.4 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -40.0 | -80.0 | 133.3 | -50.0 | 66.7 | 300.0 | -92.9 | -400.0 | -80.0 | -1,100.0 | -5,600.0 | -1,366.7 |
| 7.4 | 0.9 | 11.2 | 0.7 | 9.3 | 3.8 | 1.1 | -2.6 | 1.2 | -69.0 | -289.5 | -133.3 |
| 0.2 | 0.1 | 0.4 | 0.0 | 0.3 | 0.1 | 0.0 | -0.1 | 0.1 | -1.2 | -1.7 | -1.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -3.6 | -0.8 | 16.8 | 73.7 | -4.6 | 19.3 | -41.9 | 40.0 | 8.3 | 34.2 | -2.9 | -42.0 |
| 1 | 1 | 3 | 3 | 3 | 4 | 2 | 3 | 3 | 5 | 5 | 4 |
Operating Profit Operating ProfitCr |
| 28.8 | 19.7 | -22.7 | 5.2 | 5.3 | 4.4 | 0.0 | 6.5 | 8.2 | 5.6 | 0.4 | -50.5 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| -33.1 | -28.6 | -248.1 | 128.2 | -11.9 | 22.9 | -53.6 | 103.4 | 77.5 | 24.0 | -78.9 | -2,651.2 |
| 21.3 | 15.3 | -19.4 | 3.1 | 2.9 | 3.0 | 2.4 | 3.5 | 5.7 | 5.3 | 1.1 | -50.2 |
| 3.6 | 2.6 | -3.9 | 1.1 | 1.0 | 1.2 | 0.6 | 1.1 | 0.8 | 0.8 | 0.2 | -4.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 |
| 0 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 4 | 4 | 3 |
Current Liabilities Current LiabilitiesCr | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 4 | 7 | 7 | 6 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 1 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -1 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 1 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
| 17.3 | 116.1 | 9.7 | 41.6 | -281.9 | 254.0 | -255.1 | 84.2 | -301.0 | 121.0 | -1,436.9 |
CFO To EBITDA CFO To EBITDA% | 12.8 | 90.1 | 8.3 | 25.1 | -155.9 | 173.0 | -14,081.1 | 45.4 | -208.6 | 113.8 | -4,460.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 2 | 0 | 2 | 0 | 1 | 11 | 4 | 9 | 7 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 23.8 | 0.0 | 16.2 | 95.0 | 21.3 | 36.4 | 131.3 |
Price To Sales Price To Sales | 0.0 | 0.0 | 1.1 | 0.0 | 0.7 | 0.0 | 0.4 | 3.3 | 1.2 | 1.9 | 1.5 |
Price To Book Price To Book | 0.0 | 0.0 | 2.0 | 0.0 | 1.7 | 0.0 | 0.6 | 2.5 | 1.0 | 1.3 | 1.0 |
| -0.7 | -1.2 | -4.8 | -0.6 | 14.5 | 0.3 | 1,275.2 | 41.1 | 10.0 | 22.8 | 263.6 |
Profitability Ratios Profitability Ratios |
| 66.4 | 57.4 | 27.1 | 33.4 | 41.2 | 31.6 | 32.3 | 38.1 | 39.6 | 34.8 | 34.2 |
| 28.8 | 19.7 | -22.7 | 5.2 | 5.3 | 4.4 | 0.0 | 6.5 | 8.2 | 5.6 | 0.4 |
| 21.3 | 15.3 | -19.4 | 3.1 | 2.9 | 3.0 | 2.4 | 3.5 | 5.7 | 5.3 | 1.1 |
| 41.4 | 26.2 | -32.8 | 10.2 | 8.0 | 10.1 | 5.6 | 4.7 | 6.9 | 4.7 | 1.6 |
| 28.9 | 17.1 | -33.8 | 8.7 | 7.1 | 8.0 | 3.6 | 2.7 | 4.5 | 3.6 | 0.8 |
| 18.9 | 14.6 | -26.3 | 5.8 | 4.1 | 5.2 | 2.1 | 2.4 | 4.3 | 3.1 | 0.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
AVI Products India Limited is an Indian listed entity currently undergoing a fundamental structural and strategic transformation. Historically focused on the trading and distribution of dental healthcare and food products, the company is pivoting toward the real estate sector following a **change in control and management** initiated in **February 2026**.
---
### **Corporate Transformation & Change in Control**
The company is in a critical transition phase governed by the **SEBI (Substantial Acquisition of Shares and Takeovers) Regulations**. This shift marks the exit of the founding promoters and the entry of new leadership with a different sectoral focus.
* **The Acquirer:** **PPMS Real Estates LLP** ("Acquirer") triggered a mandatory open offer in **April 2026** to acquire up to **26%** of the voting share capital at **₹33.00 per share**.
* **Acquisition Mechanics:** The Acquirer deposited **100%** of the offer consideration (**₹2.84 crore**) into an escrow account. As of **April 2026**, the Acquirer holds an aggregate stake of **34.72%**, comprising:
* **23.68% (7,83,091 shares)** from the original Vora family promoters.
* **11.04% (3,65,030 shares)** from non-promoter sellers.
* **Management Overhaul:** The previous promoters have ceased control. The Board is being reconstituted, notably including the appointment of **Ms. Malvika Jaggani** as an Additional Non-Executive Independent Director for a **5-year** term.
* **Geographic Shift:** To align with new management, the registered office is relocating from **Vasai, Palghar** to **Khar (West), Mumbai**.
---
### **Strategic Pivot: Real Estate & Infrastructure Development**
Under the leadership of **PPMS Real Estates LLP**, AVI Products has amended its Memorandum of Association to shift its primary business objective toward the real estate industry.
* **Core Real Estate Objectives:** The company now aims to act as builders, developers, and contractors for:
* **Residential & Commercial Premises:** Flats, shops, offices, and shopping malls.
* **Specialized Infrastructure:** Software technology parks, hotels, and integrated resorts.
* **Financial Scaling for Expansion:** To facilitate this capital-intensive pivot, the company has secured shareholder approval to significantly increase its financial headroom:
* **Borrowing Limits:** Increased to **₹500 Crores**.
* **Investment/Loan Limits:** Increased to **₹500 Crores** for providing loans, guarantees, or securities.
---
### **Legacy Business Segments: Healthcare & Food**
While the company pivots to real estate, it maintains its legacy operations in the ordinary course of business. These segments provided the historical revenue base for the company.
#### **1. Dental & Healthcare Division**
* **E-commerce Distribution:** Operates the proprietary portal **'Dentaldeal.in'**, marketing dental consumables and machinery.
* **Product Strategy:** Focuses on Indian-made endodontic files and equipment, positioned as cost-effective alternatives to expensive imports. Digital marketing is used to bypass traditional dealer margins.
* **Healthcare Centers:** A **2024** initiative aimed to establish up to **300** healthcare centers in **Tier 1 and Tier 2** cities.
* **Partnerships:** Includes an agreement with **SABKADENTIST** and explorations into medical tourism and OPD consultations.
#### **2. Food & Beverages (IFRUIT Brand)**
* **Product Range:** Designs equipment for innovative ice cream formats, including **Rolls, Soft serve, Gelatos, and Sorbets**.
* **Franchise Model:** Operates a distribution model under the **IFRUIT** brand.
* **QSR Expansion:** Plans exist to establish a chain of **Quick Service Restaurants (QSR)** to capture growing fast-food demand.
---
### **Financial Performance & Capital Structure**
The company has maintained a **100% fully paid-up** equity share capital structure with no pledged shares.
#### **Key Financial Metrics**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | - | **₹5.05 Crores** | **₹3.70 Crores** |
| **Net Profit** | **₹5.37 Lakhs** | **₹25.49 Lakhs** | **₹20.56 Lakhs** |
| **Dividend** | **Nil** | **Nil** | **Nil** |
| **Audit Opinion** | **Unmodified** | **Unmodified** | **Unmodified** |
#### **Fundraising History**
* **September 2023:** Raised **₹2.61 Crore** via preferential allotment of **8,43,200** shares at **₹31** (including **₹21** premium).
* **September 2024:** Increased Authorized Capital from **₹3.50 Crore** to **₹7.50 Crore**.
* **Internal Controls:** **F P Vora & Co Chartered Accountant** serves as the Internal Auditor through **2026**, ensuring adequate financial control systems.
---
### **Related Party Exposures**
The company maintains significant financial and operational links with entities associated with the former management. These transactions require ongoing monitoring and shareholder approval.
| Entity Name | Nature of Support | Financial Limit |
| :--- | :--- | :--- |
| **Total Dental Care Pvt Ltd** | Loans, Guarantees, Securities | Up to **₹30 Crores** |
| **Bharat Jyoti Impex** | Loans, Guarantees, Securities | Up to **₹30 Crores** |
| **Healix Healthcare Pvt Ltd** | Business Requirement Support | Principal Business Activities |
---
### **Risk Profile & Investor Considerations**
#### **1. Transition and Execution Risk**
The shift from a trading/distribution model to a capital-heavy real estate and infrastructure model carries significant execution risk. The company must navigate the transition of its board and registered office while managing the **SEBI (SAST)** compliance requirements.
#### **2. Regulatory & Listing Compliance**
* **Minimum Public Shareholding (MPS):** If the acquisition by **PPMS Real Estates LLP** reduces public holding below **25%**, the company must execute a **Rights Issue, QIP, or Offer for Sale** to restore compliance.
* **Open Offer Withdrawal:** Under **Regulation 23(1)**, the offer could be withdrawn if specific conditions in the **February 2026 SPA** are not met.
#### **3. Market and Financial Risks**
* **Currency & Competition:** The dental segment is sensitive to **exchange rate volatility** and freight costs. It faces intense pressure from low-cost suppliers and rapid technological obsolescence.
* **Liquidity Risk:** The company must manage rolling forecasts to meet liabilities, especially as it scales borrowing limits to **₹500 Crores**.
* **Management Dependency:** Historically, the company relied on the expertise of **Mr. Avinash Vora** and **Mr. Vikram Vora**. The loss of their technical knowledge during the management handover may impact legacy operations.